Brooklyn ImmunoTherapeutics (NYSE:BTX) Receives New Coverage from Analysts at StockNews.com
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report report published on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Brooklyn ImmunoTherapeutics stock opened at $1.89 on Friday. The company has a market capitalization of $111.18 million, a price-to-earnings ratio of -0.83 […]
More Stories
Short Interest in 180 Degree Capital Corp. (NASDAQ:TURN) Increases By 1,825.0%
180 Degree Capital Corp. (NASDAQ:TURN – Get Free Report) was the recipient of a large increase in short interest during...
Select STOXX Europe Aerospace & Defense ETF to Issue Dividend of $0.02 (BATS:EUAD)
Select STOXX Europe Aerospace & Defense ETF (BATS:EUAD – Get Free Report) announced a dividend on Friday, December 27th,NASDAQ Dividends...
Critical Review: Research Solutions (NASDAQ:RSSS) versus Flywire (NASDAQ:FLYW)
Research Solutions (NASDAQ:RSSS – Get Free Report) and Flywire (NASDAQ:FLYW – Get Free Report) are both industrial products companies, but...
Aptus Drawdown Managed Equity ETF (ADME) to Issue Dividend of $0.04 on December 31st
Aptus Drawdown Managed Equity ETF (BATS:ADME – Get Free Report) declared a dividend on Friday, December 27th,NASDAQ Dividends reports. Stockholders...
Abacus Tactical High Yield ETF (ABHY) To Go Ex-Dividend on December 30th
Abacus Tactical High Yield ETF (BATS:ABHY – Get Free Report) declared a dividend on Friday, December 27th,NASDAQ Dividends reports. Investors...
Touchstone Ultra Short Income ETF (TUSI) to Issue Dividend of $0.11 on December 31st
Touchstone Ultra Short Income ETF (BATS:TUSI – Get Free Report) announced a dividend on Friday, December 27th,NASDAQ Dividends reports. Shareholders...